LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹0.73 Cr | ₹0.10 Cr | ₹25 Cr | - | ₹16 Cr |
What is the latest Long Term Provisions ratio of LINCOLN PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹0.73 Cr |
| Mar2024 | ₹0.10 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | - |
| Mar2021 | ₹16 Cr |
How is Long Term Provisions of LINCOLN PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.73 Cr | 656.70 | |
| Mar2024 | ₹0.10 Cr | -99.62 | |
| Mar2023 | ₹25 Cr | 0 | |
| Mar2022 | - | -100.00 | |
| Mar2021 | ₹16 Cr | - | |
Compare Long Term Provisions of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹922.6 Cr | 2.5% | -4.5% | -32.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 2.5% |
-4.5% |
-32.4% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses